Your browser doesn't support javascript.
loading
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor.
Rottmann, Matthias; Jonat, Brian; Gumpp, Christin; Dhingra, Satish K; Giddins, Marla J; Yin, Xiaoyan; Badolo, Lassina; Greco, Beatrice; Fidock, David A; Oeuvray, Claude; Spangenberg, Thomas.
Afiliação
  • Rottmann M; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Jonat B; University of Basel, Basel, Switzerland.
  • Gumpp C; Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA.
  • Dhingra SK; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Giddins MJ; University of Basel, Basel, Switzerland.
  • Yin X; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.
  • Badolo L; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.
  • Greco B; Global Statistics for NDD, Immunology, Endocrinology, Fertility & Others, EMD Serono, Billerica, Massachusetts, USA.
  • Fidock DA; Discovery and Development Technologies, Merck Healthcare KGaA, Darmstadt, Germany.
  • Oeuvray C; Global Health Institute of Merck, Eysins, Switzerland.
  • Spangenberg T; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, USA.
Article em En | MEDLINE | ID: mdl-32041711

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article